WKC Q1 2026 Earnings Massive EPS Beat Drives Consideration but Shares Edge Lower Vaxcyte PCVX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline TPST Q1 2026 Earnings Deep EPS Miss Highlights ClinicalStage Biotech Challenges